Role of uric acid in neurodegenerative diseases, focusing on Alzheimer and Parkinson disease: A new perspective
Neuropsychopharmacology Reports · 2024-09 · 44 (3) · 639-649
DOI: 10.1002/npr2.12445 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neuropsychopharmacology Reports, online erschienen am 29.07.2024. Verfasst von Mohammed Alrouji und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Shaqra University, Shaqra, Saudi Arabia. Hauptthemen laut MEDLINE: Uric Acid, Alzheimer Disease, Parkinson Disease, Hyperuricemia. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Universität Witten/Herdecke.
Themen: Demenz
Abstract (Originalsprache)
Neurodegenerative diseases (NDs) such as Alzheimer disease (AD) and Parkinson disease (PD) are group of diseases affecting the central nervous system (CNS) characterized by progressive neurodegenerations and cognitive impairment. Findings from different studies highlighted the beneficial and detrimental effects of serum uric acid on the development and progression of NDs. Therefore, this mini‐review aims to discuss the beneficial and detrimental effects of uric on NDs. The neuroprotective effect of uric acid is mainly related to the antioxidant effect of uric acid which alleviates oxidative stress‐induced neurodegeneration in AD and PD. However, long‐term effect of hyperuricemia prompts for the development and progression of cognitive impairment. Hyperuricemia is associated with cognitive impairment and dementia, and gout increases dementia risk. In addition, hyperuricemia can cause cerebral vascular injury which is a risk factor for vascular dementia and cognitive impairment. Taken together, the relationship between uric acid and NDs risk remains conflicting. Hence, preclinical and clinical studies are indicated in this regard.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Shaqra University, Shaqra, Saudi Arabia.
- Department of Clinical Pharmacology and Medicine, College of Medicine, Mustansiriyah University, Baghdad, Iraq.
- University Centre for Research & Development, Chandigarh University, Mohali, Punjab, India.
- Department of Research & Development, Funogen, Athens, Greece.
- Department of Research & Development, AFNP Med, Wien, Austria.
- Department of Science and Engineering, Novel Global Community Educational Foundation, Hebersham, New South Wales, Australia.
ORCID-Profile: Mostafa M Bahaa
Förderung
- Universität Witten/Herdecke
Zitieren
APA
Alrouji, M., Al-Kuraishy, H. M., Al-Gareeb, A. I., Alshammari, M. S., Alexiou, A., Papadakis, M., Bahaa, M. M., & Batiha, G. E. (2024). Role of uric acid in neurodegenerative diseases, focusing on Alzheimer and Parkinson disease: A new perspective. Neuropsychopharmacology Reports, 44(3), 639-649. https://doi.org/10.1002/npr2.12445
Vancouver
Alrouji M, Al-Kuraishy HM, Al-Gareeb AI, Alshammari MS, Alexiou A, Papadakis M, et al. Role of uric acid in neurodegenerative diseases, focusing on Alzheimer and Parkinson disease: A new perspective. Neuropsychopharmacology Reports. 2024;44(3):639-649. doi:10.1002/npr2.12445
BibTeX
@article{Alrouji2024,
author = {Alrouji, Mohammed and Al-Kuraishy, Hayder M and Al-Gareeb, Ali I and Alshammari, Mohammed S and Alexiou, Athanasios and Papadakis, Marios and Bahaa, Mostafa M and Batiha, Gaber El-Saber},
title = {Role of uric acid in neurodegenerative diseases, focusing on Alzheimer and Parkinson disease: A new perspective},
journal = {Neuropsychopharmacology Reports},
year = {2024},
volume = {44},
number = {3},
pages = {639--649},
doi = {10.1002/npr2.12445}
}
EUVIMED